| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |